Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation
The present invention relates to the use of a heterocyclic compound of formula I for the preparation of a medicament for the treatment or adjunctive treatment of a disease or condition associated with a RET drug resistance mutation in an individual, and to a method of treatment using said heterocycl...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HAN XIAOJUN WANG JINGYI TIAN QIANG HAN RUNFENG CHEN ZHONGHUI SONG HONGMEI YUAN XIAOXI LEI DONGMEI |
| description | The present invention relates to the use of a heterocyclic compound of formula I for the preparation of a medicament for the treatment or adjunctive treatment of a disease or condition associated with a RET drug resistance mutation in an individual, and to a method of treatment using said heterocyclic compound.
#imgabs0#本发明涉及式I的杂环化合物在制备用于治疗或辅助治疗个体中的与RET(Rearranged during transfection)耐药突变相关的疾病或病况的药物中的用途和使用所述杂环化合物的治疗方法。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116801882A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116801882A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116801882A3</originalsourceid><addsrcrecordid>eNqNizEKwkAQRdNYiHqH8QCCUZC0EhQrK61l2P0xg8lO2Jkg3t4UHsDqweO9eSF3A3GK1MNbjaQNtXBkDZ_QSaCg_aBjikaNZvIMdklPimJggxGbaRB2RHqLt_SSNHnKMDHnFED96NOjaVnMGu4Mqx8Xxfp8utWXDQZ9wAYOSPBHfS3LQ7Utq2p33P_TfAGTT0Fx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation</title><source>esp@cenet</source><creator>HAN XIAOJUN ; WANG JINGYI ; TIAN QIANG ; HAN RUNFENG ; CHEN ZHONGHUI ; SONG HONGMEI ; YUAN XIAOXI ; LEI DONGMEI</creator><creatorcontrib>HAN XIAOJUN ; WANG JINGYI ; TIAN QIANG ; HAN RUNFENG ; CHEN ZHONGHUI ; SONG HONGMEI ; YUAN XIAOXI ; LEI DONGMEI</creatorcontrib><description>The present invention relates to the use of a heterocyclic compound of formula I for the preparation of a medicament for the treatment or adjunctive treatment of a disease or condition associated with a RET drug resistance mutation in an individual, and to a method of treatment using said heterocyclic compound.
#imgabs0#本发明涉及式I的杂环化合物在制备用于治疗或辅助治疗个体中的与RET(Rearranged during transfection)耐药突变相关的疾病或病况的药物中的用途和使用所述杂环化合物的治疗方法。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230922&DB=EPODOC&CC=CN&NR=116801882A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230922&DB=EPODOC&CC=CN&NR=116801882A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAN XIAOJUN</creatorcontrib><creatorcontrib>WANG JINGYI</creatorcontrib><creatorcontrib>TIAN QIANG</creatorcontrib><creatorcontrib>HAN RUNFENG</creatorcontrib><creatorcontrib>CHEN ZHONGHUI</creatorcontrib><creatorcontrib>SONG HONGMEI</creatorcontrib><creatorcontrib>YUAN XIAOXI</creatorcontrib><creatorcontrib>LEI DONGMEI</creatorcontrib><title>Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation</title><description>The present invention relates to the use of a heterocyclic compound of formula I for the preparation of a medicament for the treatment or adjunctive treatment of a disease or condition associated with a RET drug resistance mutation in an individual, and to a method of treatment using said heterocyclic compound.
#imgabs0#本发明涉及式I的杂环化合物在制备用于治疗或辅助治疗个体中的与RET(Rearranged during transfection)耐药突变相关的疾病或病况的药物中的用途和使用所述杂环化合物的治疗方法。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQRdNYiHqH8QCCUZC0EhQrK61l2P0xg8lO2Jkg3t4UHsDqweO9eSF3A3GK1MNbjaQNtXBkDZ_QSaCg_aBjikaNZvIMdklPimJggxGbaRB2RHqLt_SSNHnKMDHnFED96NOjaVnMGu4Mqx8Xxfp8utWXDQZ9wAYOSPBHfS3LQ7Utq2p33P_TfAGTT0Fx</recordid><startdate>20230922</startdate><enddate>20230922</enddate><creator>HAN XIAOJUN</creator><creator>WANG JINGYI</creator><creator>TIAN QIANG</creator><creator>HAN RUNFENG</creator><creator>CHEN ZHONGHUI</creator><creator>SONG HONGMEI</creator><creator>YUAN XIAOXI</creator><creator>LEI DONGMEI</creator><scope>EVB</scope></search><sort><creationdate>20230922</creationdate><title>Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation</title><author>HAN XIAOJUN ; WANG JINGYI ; TIAN QIANG ; HAN RUNFENG ; CHEN ZHONGHUI ; SONG HONGMEI ; YUAN XIAOXI ; LEI DONGMEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116801882A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HAN XIAOJUN</creatorcontrib><creatorcontrib>WANG JINGYI</creatorcontrib><creatorcontrib>TIAN QIANG</creatorcontrib><creatorcontrib>HAN RUNFENG</creatorcontrib><creatorcontrib>CHEN ZHONGHUI</creatorcontrib><creatorcontrib>SONG HONGMEI</creatorcontrib><creatorcontrib>YUAN XIAOXI</creatorcontrib><creatorcontrib>LEI DONGMEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAN XIAOJUN</au><au>WANG JINGYI</au><au>TIAN QIANG</au><au>HAN RUNFENG</au><au>CHEN ZHONGHUI</au><au>SONG HONGMEI</au><au>YUAN XIAOXI</au><au>LEI DONGMEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation</title><date>2023-09-22</date><risdate>2023</risdate><abstract>The present invention relates to the use of a heterocyclic compound of formula I for the preparation of a medicament for the treatment or adjunctive treatment of a disease or condition associated with a RET drug resistance mutation in an individual, and to a method of treatment using said heterocyclic compound.
#imgabs0#本发明涉及式I的杂环化合物在制备用于治疗或辅助治疗个体中的与RET(Rearranged during transfection)耐药突变相关的疾病或病况的药物中的用途和使用所述杂环化合物的治疗方法。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116801882A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Use and method of heterocyclic compounds for treating diseases associated with kinase resistance mutation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A23%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAN%20XIAOJUN&rft.date=2023-09-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116801882A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |